Form 4 for STIM Neuronetics, Inc.
Accepted 2023-02-09 00:00:00 ET · period of report 2023-02-07 · accession 0001209191-23-008117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-09 | 2023-02-07 | STIM | MACAN WILLIAM ANDREW | SVP, GC | S - Sale | $5.99 | -5,162 | 333.6K | -2% | -$30.9K | |
| 2023-02-09 | 2023-02-08 | STIM | MACAN WILLIAM ANDREW | SVP, GC | A - Grant | $0.00 | +90.0K | 423.6K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-07 | S | D | 5,162 | $5.99 | 333,557 | D | — | — | (F1) The sales reported in this Form 4 were non-discretionary sales to satisfy the reporting person's tax withholding obligation upon vesting of a portion of a restricted stock unit award. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $5.93 to $6.06. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2023-02-08 | A | A | 90,000 | $0.00 | 423,557 | D | — | — | (F3) Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on February 8, 2024, in each case subject to continuous service of the Reporting Person through such date. (F4) Each RSU represents a contingent right to receive one share of the Issuer's common stock. |